Physician profile
Alex Witmer
NPI 1912550443
$874.30
in general payments reported to CMS, 2019-2025
15 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.68 · 2022: $16.84 · 2023: $30.68 · 2024: $373 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $816.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $148.45 | 2021-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Collegium Pharmaceutical, INC. | $144.85 | 2025 | Jornay Pm |
| Corium, LLC | $138.87 | 2024-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $73.71 | 2024 | |
| Pfizer INC. | $62.83 | 2023-2025 | |
| Sanofi Pasteur INC. | $50.96 | 2024-2025 | |
| Cranial Technologies, INC | $50.09 | 2024-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $49.13 | 2024-2025 | Qelbree |
| Sanofi-Aventis U.S. LLC | $39.32 | 2024-2025 | |
| Biomerieux INC | $34.00 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $21.73 | 2024 | Crysvita |
| Bayer Healthcare Pharmaceuticals INC. | $16.84 | 2022 | |
| Ironwood Pharmaceuticals, INC | $15.78 | 2024 | |
| Glaxosmithkline, LLC. | $14.61 | 2021 | |
| Tris Pharma INC | $13.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Witmer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.